Delivery Order SPE2DB20D3103-SPE2DB25FQ1S5
- Not listed
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency valued at $74,662.13 for the supply of Enbrel 50 mg/ml SureClick auto-injectors. The contract, awarded on September 11, 2025, with an ultimate completion date of September 12, 2025, is structured as a firm fixed price delivery order with no set-aside designation. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate office....
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $4,626.77 by the Defense Logistics Agency on April 23, 2025, for the supply of ENBREL 50 mg/mL SureClick auto-injectors. This is a firm fixed-price, non-set-aside contract with a completion date of April 24, 2025, and represents a child order under AmerisourceBergen's larger prime indefinite delivery contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $39,049.72 delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Enbrel 50 mg/mL SureClick auto-injectors. This competitively awarded, firm fixed-price contract serves as a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical will be delivered to AmerisourceBergen's corporate office...
- The Defense Logistics Agency (DLA) awarded a $35,072.01 delivery order to AmerisourceBergen Drug Corp for Enbrel 50 mg/mL SureClick auto-injectors, with an ultimate completion date of August 21, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The place of performance is listed...
- AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency (DLA) valued at $9,253.56 for the supply of Enbrel 50 mg/mL SureClick auto-injectors. This firm fixed price, competitively awarded contract carries an ultimate completion date of August 11, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under a larger indefinite delivery contract vehicle and reflects the DLA's...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $37,406.86 for Enbrel 50 mg/mL SureClick auto-injectors under a firm fixed price contract with the Defense Logistics Agency Medical Supply Chain on September 10, 2025, with completion targeted for September 11, 2025. This non-competitive delivery order represents a continuation of pharmaceutical supply to support military and veteran healthcare systems. The award is issued under AmerisourceBergen's existing Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $21,543.12 to AmerisourceBergen Drug Corp for Enbrel 50 mg/ml SureClick auto-injectors, with an ultimate completion date of September 19, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office in...
- AmerisourceBergen Drug Corp was awarded a $4,626.77 firm fixed-price delivery order by the Defense Logistics Agency (DLA) on August 21, 2025, for the supply of Enbrel 50 mg/mL SureClick auto-injectors. The contract is non-set-aside and competitively awarded, with an ultimate completion date of August 22, 2025. Performance will be executed from the company's Conshohocken, Pennsylvania location, which serves as its corporate headquarters. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $5,101.72 to AmerisourceBergen Drug Corp for Enbrel 50 mg/ml SureClick auto-injectors, with a completion date of September 12, 2025. This competitive, firm fixed-price delivery order was issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999.999 billion pharmaceutical supply vehicle that runs through December 2026. The product will be delivered to...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $10,276.74 for ENBREL 50 mg/mL SureClick auto-injectors on September 4, 2025, with completion scheduled for September 5, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. ENBREL is a biologic immunosuppressant used to treat rheumatoid arthritis, psoriasis, and...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FQ1S5Delivery Order
AmerisourceBergen Drug Corp was awarded a delivery order valued at $24,505.16 by the Defense Logistics Agency (DLA) on September 5, 2025, for the supply of Enbrel 50 mg/mL SureClick auto-injectors. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 8, 2025. The contract represents a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply agreement valued at $999,999,999.00 and extending through December 2026. Enbrel is a biologic immunosuppressant medication commonly used in military and federal healthcare settings for treating rheumatoid arthritis, psoriasis, and other autoimmune conditions. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting the Defense Health Agency and military healthcare systems. The company was competitively selected for this delivery order, demonstrating its capability to meet federal pharmaceutical supply requirements. This award exemplifies AmerisourceBergen's role within the DLA's supply chain infrastructure, which leverages the company's extensive portfolio of brand-name and generic medications, specialty pharmaceuticals, vaccines, and medical devices to support military and veteran healthcare operations globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.5k | 9/5/25 |